Detalhe da pesquisa
1.
Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo Study.
Biol Blood Marrow Transplant
; 24(2): 267-275, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29128554
2.
Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma.
Chemotherapy
; 62(3): 187-191, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28334700
3.
SARS-CoV-2 impact in a community-based hematological ward in an Italian Red Zone.
Ann Hematol
; 99(7): 1677-1678, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-32535706
4.
Mobilization-driven postconsolidation therapy in elderly patients with acute myeloid leukemia: feasibility and efficacy of autologous stem cell transplantation versus low-dose gemtuzumab ozogamicin.
Biol Blood Marrow Transplant
; 20(9): 1399-406, 2014 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-24880020
5.
Treatment options for acute myeloid leukemia patients aged <60 years.
Front Oncol
; 12: 897220, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36276074
6.
Immunological Response Against SARS-COV-2 After BNT162b2 Vaccine Administration Is Impaired in Allogeneic but Not in Autologous Stem Cell Transplant Recipients.
Front Oncol
; 11: 737300, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34552880
7.
Iron Toxicity and Chelation Therapy in Hematopoietic Stem Cell Transplant.
Transplant Cell Ther
; 27(5): 371-379, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33969823
8.
Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study.
Transplant Cell Ther
; 27(3): 244.e1-244.e8, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33781522
9.
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment.
Adv Ther
; 37(5): 2288-2302, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32297279
10.
Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score.
Bone Marrow Transplant
; 53(4): 461-473, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29330395
11.
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia.
Leuk Lymphoma
; 57(4): 965-8, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-26402469
12.
Conditioning regimen with BCNU, etoposide, cytarabine and melphalan plus amifostine for outpatient autologous stem cell transplant: feasibility and outcome in 97 patients with lymphoma.
Leuk Lymphoma
; 55(7): 1657-60, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24024474